NCT03557697

Brief Summary

Chinese Americans are one of the fastest growing immigrant groups in the US, who suffer disproportionately high type 2 diabetes (T2D) burden and have poorly controlled T2D. Despite the well-documented T2D disparities in this minority group, limited work has been conducted to improve health outcomes in Chinese Americans. The goal of this Pathway to Independence Award (K99/R00) is to expedite the candidate's transition to an independent investigator who possesses focused expertise in development and evaluation of culturally and linguistically tailored and sustainable interventions to reduce T2D disparities in Chinese Americans. In the K99 phase of this award, the candidate will obtain critical training needed to accomplish this goal and will develop a short message service (SMS) intervention to improve T2D management in Chinese Americans. More specifically, the aims are to 1) characterize barriers and facilitators of glycemic control in Chinese Americans with T2D (Aim 1a); 2) develop culturally and linguistically tailored SMS intervention content (Aim 1b); and 3) assess the feasibility and acceptability of the SMS intervention in a pre-, post-test study (Aim 1c). In the R00 phase, the candidate will refine the SMS intervention based on the K99 pilot data and evaluate the proof-of-concept regarding its efficacy in a pilot randomized controlled trial among 66 Chinese Americans with T2D (Aim 2). Participants will be randomized to one of 2 arms (n=30 each): 1) wait-list control and 2) SMS intervention. Both groups will continue to receive standard of care treatment for their T2D. The SMS group will receive brief lifestyle counseling videos via SMS links. At the end of the study, the wait-list control group will be provided the opportunity to receive the SMS-based counseling videos. Measurements will be obtained at baseline, 3, and 6 months. The primary outcome is HbA1c and secondary outcomes include self-efficacy, diabetes self-management behaviors, dietary intake and physical activity behaviors. Linear mixed modeling will be used to examine the group and group by time interaction effects between the SMS intervention and wait-list control group. Findings from this R00 study will inform a larger full-scale R01 efficacy trial of the SMS intervention, and ultimately, establish the candidate's program of research focused on developing and testing sustainable interventions to reduce disparities in chronic disease outcomes in Chinese Americans. This project can serve as a program model for other chronic disease interventions in Chinese Americans that require lifestyle modification (e.g., prediabetes, hypertension), or for disparities research in other high-risk immigrant populations (e.g., South Asians, Hispanic Americans).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 15, 2018

Completed
2.7 years until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 21, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 21, 2023

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

December 27, 2024

Completed
Last Updated

February 19, 2025

Status Verified

January 1, 2025

Enrollment Period

2.1 years

First QC Date

June 4, 2018

Results QC Date

November 20, 2024

Last Update Submit

January 29, 2025

Conditions

Keywords

Chinese AmericansSMS intervention

Outcome Measures

Primary Outcomes (2)

  • Change in Average Plasma Glucose Concentration Measured by Hemoglobin A1c (HbA1c) Levels

    HbA1c testing results abstracted from medical record.

    Baseline, Month 3

  • Change in Average Plasma Glucose Concentration Measured by Hemoglobin A1c (HbA1c) Levels

    HbA1c testing results abstracted from medical record.

    Baseline, Month 6

Secondary Outcomes (32)

  • Change in Stanford Diabetes Self-Efficacy Scale Score

    Baseline, Month 3

  • Change in Stanford Diabetes Self-Efficacy Scale Score

    Baseline, Month 6

  • Change in Summary of Diabetes Self-Care Activities (SDSCA) - General Diet Score

    Baseline, Month 3

  • Change in Summary of Diabetes Self-Care Activities (SDSCA) - General Diet Score

    Baseline, Month 6

  • Change in Summary of Diabetes Self-Care Activities (SDSCA) - Specific Diet Score

    Baseline, Month 3

  • +27 more secondary outcomes

Study Arms (2)

wait-list control

ACTIVE COMPARATOR

3 measurement visits, baseline, 3, and 6 months

Behavioral: Standard of Care

SMS intervention

ACTIVE COMPARATOR

3 measurement visits, baseline, 3, and 6 months

Behavioral: SMS Intervention

Interventions

At the end of the study the control group will be provided with the opportunity to receive counseling videos delivered via SMS

wait-list control

Participants in the intervention group will receive SMS based video counseling which include both educational and SCT=-based behavioral content. In addition, participants will receive biweekly phone calls from study community health workers to review the video content and clarify questions, set goals, and problem-solve barriers to achieving the goals.

SMS intervention

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • self-identify as Chinese Immigrant or Chinese American
  • be able to speak and understand Mandarin
  • self-report a diagnosis of T2D
  • baseline HbA1c ≥ 7%
  • be currently using WeChat or text messages• be willing to receive WeChat or text messages regarding T2D management
  • express strong interest and confidence in finishing watching 2 diabetes videos each week for a total of 12 weeks
  • express motivation to make lifestyle changes to control their diabetes
  • be willing to wear ActiGraph for 8 days

You may not qualify if:

  • unable or unwilling to provide informed consent
  • unable to participate meaningfully in the intervention (e.g., uncorrected sight and hearing impairment)
  • unwilling to accept randomization assignment
  • pregnant, plans to becomes pregnant in the next 6 months, or who become pregnant during the study
  • breastfeeding
  • live in a facility or other health care setting where they have to control over diabetes self-management

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

Location

Related Publications (3)

  • Liu J, Cao J, Shi Y, Sevick MA, Islam N, Feldman N, Li H, Wang C, Zhao Y, Tamura K, Levy N, Jiang N, Zhu Z, Wang Y, Hong J, Hu L. A Culturally and Linguistically Tailored Intervention to Improve Diabetes-Related Outcomes in Chinese Americans With Type 2 Diabetes: Pilot Randomized Controlled Trial. JMIR Mhealth Uhealth. 2025 Oct 27;13:e78036. doi: 10.2196/78036.

  • Shi Y, Sevick MA, Tang H, Wang C, Zhao Y, Yoon S, Li H, Jiang Y, Bai Y, Ong IH, Yang X, Su L, Levy N, Tamura K, Hu L. Culturally Tailored Social Media Intervention Improves Health Outcomes in Chinese Americans with Type 2 Diabetes: Preliminary Evidence from a Pilot RCT. J Gen Intern Med. 2025 Jul;40(10):2319-2329. doi: 10.1007/s11606-025-09430-9. Epub 2025 Feb 27.

  • Hu L, Islam N, Zhang Y, Shi Y, Li H, Wang C, Sevick MA. Leveraging Social Media to Increase Access to an Evidence-Based Diabetes Intervention Among Low-Income Chinese Immigrants: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2022 Oct 28;11(10):e42554. doi: 10.2196/42554.

MeSH Terms

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Results Point of Contact

Title
Lu Hu
Organization
NYU Langone Health

Study Officials

  • Lu Hu, PhD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2018

First Posted

June 15, 2018

Study Start

March 1, 2021

Primary Completion

April 21, 2023

Study Completion

April 21, 2023

Last Updated

February 19, 2025

Results First Posted

December 27, 2024

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Shared Documents
STUDY PROTOCOL, SAP, ICF
Access Criteria
Requests should be directed to Lu.Hu@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.

Locations